A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Recruiting

Phase 2

BI 764524A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Sponsor:

Boehringer Ingelheim

Code:

NCT06321302

Conditions

Diabetic Retinopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 764524

Sham comparator to BI 764524

Aflibercept (Eylea®) - US only

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2025-05-16.